[ad_1]
The U.S. stock market is on pace to finish the first half of 2024 on a positive note. If the past is any guide, the good times for U.S. equities may keep rolling into July, but not every stock may enjoy this summertime rally.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...